You Are Not Alone With Postpartum Depression

What It Covers

Josh and Chuck cover postpartum depression and related maternal mental health conditions, including postpartum psychosis, OCD, and mood/anxiety disorders. They examine biological causes, racial disparities in diagnosis and treatment, the role of the hormone allopregnanolone, and available treatments including two FDA-approved drugs targeting the condition directly.

Key Questions Answered

• •Scope and severity: Approximately 1 in 8 women (12%) experience postpartum depression, but rates of PPD were seven times higher in 2015 than in 2000. Between 2016 and 2023, new mothers reported a 65% increase in fair-to-poor mental health. Suicide and drug overdose now account for 22% of all postpartum maternal deaths in the US, making it the leading cause of death among new mothers.
• •Baby blues vs. PPD distinction: Baby blues and postpartum depression share identical symptoms — loss of appetite, insomnia, mood swings, anxiety, bonding difficulty, and guilt. The differentiating factors are severity and duration. If symptoms persist beyond one to two weeks, PPD is likely. PPD can also onset several weeks after birth, so monitoring should continue well past the initial postpartum period.
• •Racial disparities in diagnosis and treatment: Up to 40% of Black and Latina mothers experience PPD — roughly twice the rate of non-Hispanic white mothers. Black women are 41% less likely and Latina women 57% less likely to begin treatment. Standard screening tools like the Edinburgh Postnatal Depression Scale miss PPD in Black women, whose symptoms present as irritability, fatigue, and insomnia rather than classic depressive markers.
• •Allopregnanolone and targeted medication: Allopregnanolone, a brain-produced steroid that acts as a natural antidepressant during pregnancy, drops sharply within 72 hours of birth — functionally equivalent to abruptly stopping an antidepressant after nine months. Two drugs, brexanolone and zuranolone, specifically target this hormonal crash. SSRIs paroxetine and sertraline are preferred for nursing mothers due to shorter half-lives and lower transfer rates into breast milk.
• •Partner and environmental interventions: Sleep deprivation is a primary environmental trigger for PPD and a key risk factor for postpartum psychosis, particularly in women with personal or family history of bipolar disorder. Partners should take overnight feedings to maximize maternal sleep. Mothers should leave the home as early as feasible. Between 8–10% of new fathers also experience postpartum depression, typically emerging three to six months after birth.